Smith Kathryn E KE

Show results for

Unknown (3)
Metabolomics (1)

Repository

MetaboLights (1)

Technology Type

Mass spectrometry (1)

Instrument Platform

Liquid Chromatography MS - alternating - hilic (1)

Publication Date

2021 (1)

CHEBI ID

CHEBI:1157 (1)
CHEBI:1237 (1)
CHEBI:131692 (1)
CHEBI:131694 (1)
CHEBI:131924 (1)
CHEBI:132188 (1)
CHEBI:133140 (1)
CHEBI:133657 (1)
CHEBI:134365 (1)
CHEBI:134428 (1)
CHEBI:134451 (1)
CHEBI:134510 (1)
CHEBI:136235 (1)
CHEBI:136236 (1)
CHEBI:136248 (1)
CHEBI:136262 (1)
CHEBI:136263 (1)
CHEBI:136272 (1)
CHEBI:136273 (1)
CHEBI:136348 (1)
CHEBI:136361 (1)
CHEBI:136371 (1)
CHEBI:136479 (1)
CHEBI:137055 (1)
CHEBI:137118 (1)
CHEBI:137139 (1)
CHEBI:137143 (1)
CHEBI:137144 (1)
CHEBI:137146 (1)
CHEBI:137147 (1)

Metabolite Name

(+)-15-nor-4-thujopsen-3-one (1)
(+)-Adlumine (1)
(+)-gamma-Hydroxy-L-homoarginine (1)
(+/-)-5-[(tert-Butylamino)-2'-hydroxypropoxy]-1,2,3,4-tetrahydro-1- naphthol (1)
(-)-2-((3,5-Dihydroxy-4-methoxyphenyl)methyl)-2,4,6-trihydroxy-3(2H)-benzofuranone (1)
(1-Ribosylimidazole)-4-acetate (1)
(25R)-3alpha,7alpha-dihydroxy-5beta-cholestan-27-oyl taurine (1)
(2R,3S)-3-Isopropylmalate (1)
(2S)-2-Isopropylmalate (1)
(2S)-2-{[1-(R)-Carboxyethyl]amino}pentanoate (1)
(3'-sulfo)Galbeta-Cer(d18:0/2-OH-20:0) (1)
(3'-sulfo)Galbeta-Cer(d18:0/2-OH-24:1(15Z)) (1)
(3R)-beta-Leucine (1)
(5Z,7E)-9,10-seco-5,7,10(19)-cholestatriene (1)
(9Z)-Hexadecenoic acid (1)
(9Z)-Tetradecenoic acid (1)
(R)-2-Hydroxyglutarate (1)
(R)-3-((R)-3-Hydroxybutanoyloxy)butanoate (1)
(R)-Lactate (1)
(S)-1-Pyrroline-5-carboxylate (1)
(S)-2-Aceto-2-hydroxybutanoate (1)
(S)-2-Acetolactate (1)
(S)-2-Amino-3-(3-hydroxy-4-oxo-4H-pyridin-1-yl)propanoate (1)
(S)-3-Methyl-2-oxopentanoic acid (1)
(S)-ATPA (1)
(S)-Dihydroorotate (1)
(S)-Malate (1)
1(2H)-Isoquinolinone (1)
1,13-Dihydroxy-herbertene (1)
1,2-Bis(4-nitrophenyl)ethane (1)

Release Date

2024 (1)
2022 (1)
2021 (1)

Previous page
1 / 1
You're on page 1
Next page

Sort by:

Relevance

Page size

Transcriptional differentiation of Trypanosoma brucei during in vitro acquisition of resistance to acoziborole

Subspecies of the protozoan parasite Trypanosoma brucei are the causative agents of Human African Trypanosomiasis (HAT), a debilitating neglected tropical disease prevalent across sub-Saharan Africa. HAT case numbers have steadily decreased since the start of the century, and sustainable...

2021-11-02 | MTBLS2559 | MetaboLights

Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation.

Not available

S-EPMC11249957 | biostudies-literature

Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab.

Not available

S-EPMC9422774 | biostudies-literature

Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol.

Not available

S-EPMC8822604 | biostudies-literature